shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin. Archid R, Zieker D, Weinreich FJ, Hones F, et al. Eur J Surg Oncol 2020;46.

Read + Share

Amedeo Smart

Independent Medical Education